Evaluation of hematological inflammatory parameters in patients with chronic migraine: a pilot study
Headache Medicine · 10.04.2026 · 17 (1) · 65-71
DOI: 10.48208/headachemed.2026.8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Headache Medicine, online erschienen am 10.04.2026. Verfasst von Aline Vitali-Silva und 8 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
IntroductionMigraine is a prevalent and disabling neurological disorder characterized by recurrent attacks of severe, pulsating, unilateral headache accompanied by phonophobia, photophobia, nausea and/or vomiting. Its pathophysiology involves sterile inflammation within the cortex–meninges interface and activation of the trigeminal system. Despite its burden, there are still no laboratory biomarkers established in routine clinical practice for diagnosis, monitoring, or prognostic assessment.ObjectiveTo investigate the feasibility of complete blood count (CBC)–derived parameters and composite indices as potential biomarkers in migraine.MethodsThis retrospective case–control study included individuals aged 18–69 years with chronic migraine and age- and sex-matched controls without migraine. CBC parameters and combined indices were analyzed, including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), neutrophil-to-monocyte ratio (NMR), lymphocyte-to-monocyte ratio (LMR), and platelet-to-monocyte ratio (PMR).ResultsTwenty-five patients with migraine and 29 controls were included. Patients with migraine had a significantly higher NMR compared with controls [11.42 (8.53–12.94) vs 7.76 (6.13–10.17); p=0.029]. No differences were observed in individual CBC parameters or in the other ratios evaluated.ConclusionThese findings suggest a predominance of neutrophil-related activity in migraine-associated inflammation. Larger, prospective studies are needed to validate the diagnostic and prognostic value of NMR.
Zitieren
APA
Vitali-Silva, A., Silva, M. M., Pavão, V. M., Franco, I. N., Vitro, M. F. P., Zapelini, C., Netto, L. A., Imai, L. M. H., & Oliveira, D. J. P. C. D. (2026). Evaluation of hematological inflammatory parameters in patients with chronic migraine: a pilot study. Headache Medicine, 17(1), 65-71. https://doi.org/10.48208/headachemed.2026.8
Vancouver
Vitali-Silva A, Silva MM, Pavão VM, Franco IN, Vitro MFP, Zapelini C, et al. Evaluation of hematological inflammatory parameters in patients with chronic migraine: a pilot study. Headache Medicine. 2026;17(1):65-71. doi:10.48208/headachemed.2026.8
BibTeX
@article{VitaliSilva2026,
author = {Vitali-Silva, Aline and Silva, Matheus Marengoni and Pavão, Victor Mateus and Franco, Isabelly Novaski and Vitro, Maria Fernanda Possari and Zapelini, Caroline and Netto, Luiz Araujo and Imai, Lia Maki Hatisuka and Oliveira, Dilter José Picin Correa de},
title = {Evaluation of hematological inflammatory parameters in patients with chronic migraine: a pilot study},
journal = {Headache Medicine},
year = {2026},
volume = {17},
number = {1},
pages = {65--71},
doi = {10.48208/headachemed.2026.8}
}
EUVIMED